3 Reasons Why Caribou Biosciences Is a Screaming Buy in July and Beyond

3 Reasons Why Caribou Biosciences Is a Screaming Buy in July and Beyond

Submitted by admin on July 28, 2023 - 10:38am
Source: 
Motley Fool
News Tags: 
Caribou Biosciences
cell therapy
CB-010
relapsed or refractory B cell lymphoma
Headline: 
3 Reasons Why Caribou Biosciences Is a Screaming Buy in July and Beyond
snippet: 
  • Caribou's cell therapy programs are among the most advanced that exist.
  • So far, they also appear to be relatively safe and quite effective.
  • The company has more than enough money to reach its next clinical milestones.

Do Not Allow Advertisers to Use My Personal information